An early response to immunotherapy predicts higher overall survival and progression-free survival outcomes in metastatic renal cell carcinoma patients

Saved in:
Bibliographic Details
Published in:European urology open science (Online) 2021-11, Vol.33, p.S336
Main Authors: Ojeda Claro, A.V., Ruíz-Guerrero, E., Ledo Cepero, M.J., Rosety-Rodríguez, J., Soto-Delgado, M., Álvarez-Ossorio, J.L.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2666-1683
2666-1683
DOI:10.1016/S2666-1683(21)03171-2